Repligen
RGEN
#2045
Rank
C$12.82 B
Marketcap
C$227.92
Share price
-0.47%
Change (1 day)
13.84%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : C$1.03 Billion

According to Repligen 's latest financial reports the company has C$1.03 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.08 B9.06%
2023-12-31C$0.99 B17.73%
2022-12-31C$0.84 B9.99%
2021-12-31C$0.76 B-15.86%
2020-12-31C$0.91 B32.53%
2019-12-31C$0.69 B161.38%
2018-12-31C$0.26 B20.86%
2017-12-31C$0.21 B14.66%
2016-12-31C$0.19 B91.36%
2015-12-31C$99.56 M46.78%
2014-12-31C$67.83 M3.41%
2013-12-31C$65.59 M64.69%
2012-12-31C$39.83 M
2011-03-31C$48.12 M-10.18%
2010-03-31C$53.57 M-12.83%
2009-03-31C$61.46 M21.71%
2008-03-31C$50.49 M92.79%
2007-03-31C$26.19 M17.94%
2006-03-31C$22.2 M6.35%
2005-03-31C$20.88 M14.47%
2004-03-31C$18.24 M-20%
2003-03-31C$22.8 M-31.41%
2002-03-31C$33.24 M-11.99%
2001-03-31C$37.77 M-23.72%
2000-03-31C$49.52 M894.71%
1999-03-31C$4.97 M-25.3%
1998-03-31C$6.66 M37.63%
1997-03-31C$4.84 M-48.2%
1996-03-31C$9.34 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
C$1.05 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.04 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.54 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$18.66 B 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$4.89 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$22.79 B 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$20.70 B 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.20 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$40.91 M-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$0.28 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA